What does Coenzyme-A Inc. do?

Coenzyme-A Inc. (PPII) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is PPII's market cap?

Coenzyme-A Inc. (PPII) has a market capitalization of approximately $111, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does PPII pay a dividend?

No — Coenzyme-A Inc. (PPII) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Coenzyme-A Inc. (PPII) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

PPII

Coenzyme-A Inc.

OTC·Drug Manufacturers, Specialty & Generic · Healthcare

$0.00$0.00+0.00%

Market cap$111.00·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−83.33%CAGR −30.12%

Select date range

FromTo

Dec 16, 2008Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

PPII does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

Income Statement Flow

PRO

See exactly how PPII's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for PPII and 80,000+ other tickers.

About Coenzyme-A Inc.

Coenzyme-A Inc. specializes in the development and manufacturing of nutraceutical supplements, alongside a comprehensive range of skincare and haircare products, which it distributes across the United States and internationally. Its extensive product portfolio includes vitality-boosting beverages and rejuvenating facial serums. The company also formulates solutions for weight management, various dermatological concerns, and the support of healthy fatty acid and cholesterol metabolism. Additionally, Coenzyme-A Inc. offers nutritional blends specifically designed to bolster bone, joint…

CEO: Nickoloaus D. Skouras
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: OTC
Employees: 0
Website: www.coenzymea.com

Peers

Peers Tab

BRSF

Brain Scientific Inc.

Clever Leaves Holdings Inc.

Cap

$175.0

Latest News

News Tab

No recent news available.

Frequently Asked Questions About PPII

What does Coenzyme-A Inc. do?: Coenzyme-A Inc. (PPII) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is PPII's market cap?: Coenzyme-A Inc. (PPII) has a market capitalization of approximately $111, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does PPII pay a dividend?: No — Coenzyme-A Inc. (PPII) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is PPII profitable?: Coenzyme-A Inc. (PPII) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.